Sanofi, Lexicon sign diabetes licence and collaboration deal
November 06, 2015 at 01:34 AM EST
Nov 6 (Reuters) - Sanofi has agreed to collaborate with Lexicon Pharmaceuticals on Sotagliflozin, a potential oral treatment for people with diabetes, the French drugmaker said on Friday.
